858 Therapeutics
San Diego, CA
858 Therapeutics is a biotechnology and drug discovery company developing a portfolio of small molecule drugs that act on novel therapeutic targets in oncology, including proteins that regulate RNA and the innate immune response.
8five8tx.comCompany Details
Founded
- 2019
Employees
- Between 20 - 50 employees
Raised
- $130,056,096
Headquarters Location
- San Diego, CA
Public
- No
Acquired
- No
CEO
Jeffrey Stafford
Founders
- Jeffrey StaffordGretchen BainJim Veal
Company Collections
These are collections 858 Therapeutics is a part of. Click on the collection name to view similar companies.
858 Therapeutics' Industries
858 Therapeutics Headquarters Location
3115 Merryfield Row, San Diego, CA 92121
Total Amount Raised: $130,056,096
858 Therapeutics Funding Rounds
Series B
$50,000,000
Series B Investors
Avidity Partners ManagementAlexandria Real Estate EquitiesMirae Asset CapitalInsight Venture PartnersVersant VenturesNEA - New Enterprise AssociatesLogos CapitalSeries A
$60,000,000
Series A Investors
Versant VenturesLogos CapitalCormorant Asset ManagementNEA - New Enterprise AssociatesSeries Unknown
$20,056,095
Funding info provided by Diffbot.
858 Therapeutics Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on 858 Therapeutics.